Clinical significance of midkine expression in sporadic desmoid tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hee Sung | - |
dc.contributor.author | Kim, Jin | - |
dc.contributor.author | Nam, Kyung Han | - |
dc.contributor.author | Kim, Woo Ho | - |
dc.date.available | 2019-03-08T13:38:00Z | - |
dc.date.issued | 2016-03 | - |
dc.identifier.issn | 1792-1074 | - |
dc.identifier.issn | 1792-1082 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/7200 | - |
dc.description.abstract | The aim of the present study was to identify the prognostic factors for the propensity for recurrence in sporadic desmoid tumors. The catenin (cadherin-associated protein) 1 (CTNNB1) genotypes and expression of Wnt pathway proteins and midkine (also termed neurite growth-promoting factor 2) were investigated in 159 patients with sporadic desmoid tumors. Formalin-fixed paraffin-embedded tissues of the surgically resected desmoid tumors were examined by direct sequencing of CTNNB1 exon 3, and immunostained for the expression of -catenin, T-cell factor 4 (TCF-4), phosphorylated protein kinase B (pAkt), midkine and menin using a tissue microarray method. Among the samples, 70% (111/159) exhibited point mutations of the CTNNB1 gene, including T41A (56%), S45F (8%), S45P (2%), S45N (2%) and T42A (1%). In addition, 100, 57, 24, 15 and 92% of the tumors expressed -catenin, TCF-4, midkine, pAkt and menin, respectively. Positive midkine expression was significantly associated with the recurrence of tumors (P=0.001). The multivariate analysis of recurrence demonstrated that an extra-abdominal tumor site [hazard ratio (HR), 2.625; P=0.001] and midkine expression (HR, 2.077; P<0.009) were independent prognostic factors of tumor recurrence. In conclusion, the present results suggest that the tumor site and midkine expression may be predictive markers for the recurrence of sporadic desmoid tumors. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.title | Clinical significance of midkine expression in sporadic desmoid tumors | - |
dc.type | Article | - |
dc.identifier.doi | 10.3892/ol.2016.4129 | - |
dc.identifier.bibliographicCitation | ONCOLOGY LETTERS, v.11, no.3, pp 1677 - 1684 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000371634000010 | - |
dc.identifier.scopusid | 2-s2.0-84958064268 | - |
dc.citation.endPage | 1684 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1677 | - |
dc.citation.title | ONCOLOGY LETTERS | - |
dc.citation.volume | 11 | - |
dc.type.docType | Article | - |
dc.publisher.location | 그리이스 | - |
dc.subject.keywordAuthor | midkine | - |
dc.subject.keywordAuthor | CTNNB1 | - |
dc.subject.keywordAuthor | desmoid tumor | - |
dc.subject.keywordAuthor | recurrence | - |
dc.subject.keywordPlus | BETA-CATENIN MUTATIONS | - |
dc.subject.keywordPlus | FIBROMATOSIS | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | GENE | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.